KLF4 and pancreatic neoplasm: In the same study, the authors showed that DIM significantly induced miR-152 expression, blocking DNMT1, its binding to KLF4 promoter, thus, activating KLF4 expression, and inhibiting cell growth in vitro and tumorigenesis in animal models of pancreatic cancer [154].